Orteq Shares 5-Year Study Data for Actifit Meniscal Scaffold

Results from a multi-center study of Orteq Sports Medicine's Actifit® meniscal scaffold revealed a greater than 87% survival rate at five-year follow-up, with increased knee function and reduced pain.

Actifit has been implanted in more than 4,000 patients with irreparable meniscal cartilage damage in 30 countries. The synthetic...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us